Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 416

1.

miRNA regulation during cardiac development and remodeling in cardiomyopathy.

Chaitra KL, Ulaganathan K, James A, Ananthapur V, Nallari P.

EXCLI J. 2013 Nov 26;12:980-92. eCollection 2013. Review.

2.

Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.

Xing T, He H.

Chin J Cancer Res. 2016 Feb;28(1):80-91. doi: 10.3978/j.issn.1000-9604.2016.02.09. Review.

3.

MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2.

Ma M, He M, Jiang Q, Yan Y, Guan S, Zhang J, Yu Z, Chen Q, Sun M, Yao W, Zhao H, Jin F, Wei M.

Int J Biol Sci. 2016 Feb 5;12(4):397-408. doi: 10.7150/ijbs.13475. eCollection 2016.

4.

Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition.

Lin CW, Lin PY, Yang PC.

Stem Cells Int. 2016;2016:2732705. doi: 10.1155/2016/2732705. Epub 2016 Feb 16. Review.

5.
6.

MicroRNAs in colorectal carcinoma--from pathogenesis to therapy.

Chi Y, Zhou D.

J Exp Clin Cancer Res. 2016 Mar 10;35:43. doi: 10.1186/s13046-016-0320-4. Review.

7.

Cancer stem cells and chemoresistance: The smartest survives the raid.

Zhao J.

Pharmacol Ther. 2016 Apr;160:145-58. doi: 10.1016/j.pharmthera.2016.02.008. Epub 2016 Feb 17. Review.

PMID:
26899500
8.

Effect of Huai Qi Huang on Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through miR-200a.

Pu J, Zhang Y, Zhou J.

Evid Based Complement Alternat Med. 2016;2016:8612190. doi: 10.1155/2016/8612190. Epub 2016 Jan 14.

9.

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.

Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AK.

Cancer Discov. 2016 Mar;6(3):235-46. doi: 10.1158/2159-8290.CD-15-0893. Epub 2016 Feb 10. Review.

PMID:
26865249
10.

Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.

Choi YJ, Baek GY, Park HR, Jo SK, Jung U.

PLoS One. 2016 Jan 22;11(1):e0147343. doi: 10.1371/journal.pone.0147343. eCollection 2016.

11.

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam KC, Muñoz-Antonia T, Qu X, Eschrich S, Uramoto H, Tanaka F, Nasarre P, Gemmill RM, Roche J, Drabkin HA, Haura EB.

PLoS One. 2016 Jan 20;11(1):e0147344. doi: 10.1371/journal.pone.0147344. eCollection 2016.

12.

MicroRNA Regulation of Epithelial to Mesenchymal Transition.

Abba ML, Patil N, Leupold JH, Allgayer H.

J Clin Med. 2016 Jan 14;5(1). pii: E8. doi: 10.3390/jcm5010008. Review.

13.

MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer.

Pal MK, Jaiswar SP, Dwivedi VN, Tripathi AK, Dwivedi A, Sankhwar P.

Cancer Biol Med. 2015 Dec;12(4):328-41. doi: 10.7497/j.issn.2095-3941.2015.0024. Review.

14.

Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer.

Yang Y, Liu H, Wang X, Chen L.

Int J Clin Exp Med. 2015 Oct 15;8(10):18123-9. eCollection 2015.

15.

Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition.

Gu S, Liu Y, Zhu B, Ding K, Yao TP, Chen F, Zhan L, Xu P, Ehrlich M, Liang T, Lin X, Feng XH.

J Biol Chem. 2016 Mar 4;291(10):5396-405. doi: 10.1074/jbc.M115.713123. Epub 2016 Jan 13.

PMID:
26763233
16.

The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.

Ungewiss C, Rizvi ZH, Roybal JD, Peng DH, Gold KA, Shin DH, Creighton CJ, Gibbons DL.

Sci Rep. 2016 Jan 5;6:18652. doi: 10.1038/srep18652.

17.

Identification and characterization of Clonorchis sinensis cathepsin B proteases in the pathogenesis of clonorchiasis.

Chen W, Ning D, Wang X, Chen T, Lv X, Sun J, Wu D, Huang Y, Xu J, Yu X.

Parasit Vectors. 2015 Dec 21;8:647. doi: 10.1186/s13071-015-1248-9.

18.

miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review.

Alemar B, Gregório C, Ashton-Prolla P.

Biomark Insights. 2015 Dec 13;10:113-24. doi: 10.4137/BMI.S27679. eCollection 2015. Review.

19.

MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer.

Mathe A, Scott RJ, Avery-Kiejda KA.

Int J Mol Sci. 2015 Nov 30;16(12):28347-76. doi: 10.3390/ijms161226090. Review.

20.

Up-regulation of AKAP13 and MAGT1 on cytoplasmic membrane in progressive hepatocellular carcinoma: a novel target for prognosis.

Molee P, Adisakwattana P, Reamtong O, Petmitr S, Sricharunrat T, Suwandittakul N, Chaisri U.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9796-811. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk